Vincerx Pharma, Inc. (VINC)
NASDAQ: VINC · IEX Real-Time Price · USD
0.634
-0.016 (-2.46%)
Jul 22, 2024, 10:12 AM EDT - Market open
Vincerx Pharma Employees
Vincerx Pharma had 42 employees as of December 31, 2023. The number of employees increased by 1 or 2.44% compared to the previous year.
Employees
42
Change (1Y)
1
Growth (1Y)
2.44%
Revenue / Employee
n/a
Profits / Employee
-$910,595
Market Cap
19.69M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 42 | 1 | 2.44% |
| Dec 31, 2022 | 41 | -15 | -26.79% |
| Dec 31, 2021 | 56 | 28 | 100.00% |
| Dec 31, 2020 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Aspira Women's Health | 64 |
| Cara Therapeutics | 55 |
| MEI Pharma | 46 |
| Kala Pharmaceuticals | 43 |
| American Shared Hospital Services | 31 |
| iBio, Inc. | 26 |
| NeurAxis | 19 |
| Iterum Therapeutics | 14 |
VINC News
- 2 months ago - Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants - GlobeNewsWire
- 3 months ago - Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants - GlobeNewsWire
- 3 months ago - Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 - GlobeNewsWire
- 4 months ago - Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update - GlobeNewsWire
- 4 months ago - Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024 - GlobeNewsWire
- 7 months ago - Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma - GlobeNewsWire
- 8 months ago - Vincerx Pharma Presents Preclinical VIP943 and VIP924 Posters at ASH 2023 - GlobeNewsWire